Brief: Adial Pharmaceuticals- On Feb 28, Got Notification From Nasdaq Granting Request For 180-Day Extension To Regain Compliance With Min Bid Price Requirement
02/03/2023 12:21
Adial Pharmaceuticals Inc ADIL.O :
* ADIAL PHARMACEUTICALS- ON FEB 28, GOT NOTIFICATION FROM
NASDAQ
GRANTING REQUEST FOR 180-DAY EXTENSION TO REGAIN COMPLIANCE WITH
MIN BID PRICE REQUIREMENT
Source text for Eikon: ID:
Further company coverage: ADIL.O
Recent news on Adial Pharmaceuticals
See all newsBrief: Adial Pharmaceuticals Announces Name Change To Azora Therapeutics
Brief: Adial Pharmaceuticals Announces Planned Appointment Of Celia Economides As Chief Financial Officer
Brief: Adial Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Brief: Adial Pharmaceuticals - Proposed Resale Of Up To 25,148,970 Shares Of Common Stock By Selling Stockholders - SEC Filing
Brief: Adial Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)